Trxade Group (MEDS) Osake Kurssi
Trxade Group Kurssi
Viimeisten 13 vuoden aikana Trxade Groupn liikevaihto kasvoi 29,6 % vuodessa ja ylsi 23,34 M USD:een. Trxade Groupn nettomarginaali −433,9 % on laskenut verrattuna −15,0 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 3,14 %. Trxade Groupn 12 kuukauden konsensustavoitehinta on 6,89 USD, noin yli kurssia 127,2 %. 7 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
Trxade Group osakekurssi
Trxade Group liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Trxade Group -osakkeesta
Trxade Group Inc's business model involves operating a web-based healthcare platform, aiming to improve access and affordability of pharmaceutical products to independent pharmacies. The company utilizes technology to connect independent pharmacists with suppliers and manufacturers, creating a transparent marketplace for purchasing and delivering drugs at competitive prices. Trxade Group Inc further offers various services such as prescription and lab testing, consulting, and data analytics to support independent pharmacies in enhancing their operational efficiency and profitability. Through their innovative approach, Trxade Group Inc strives to empower independent pharmacies in the competitive healthcare industry.
Trxade Group Inc is primarily active in the healthcare and pharmaceutical industries.
The main competitors of Trxade Group Inc in the market include pharmaceutical wholesalers and distributors such as McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health Inc. These well-established companies operate on a larger scale compared to Trxade, serving a diverse range of customers including hospitals, retailers, and pharmacies. However, Trxade differentiates itself by focusing on independent pharmacies and providing a comprehensive web-based purchasing platform, offering competitive pricing and efficient inventory management solutions tailored to the needs of its target market.
Trxade Group Inc, founded in 2010, is a leading pharmaceutical supply chain platform in the United States. The company operates Trxade.com, an online marketplace connecting independent pharmacies with suppliers. Trxade's innovative technology and business models aim to revolutionize the healthcare and pharmaceutical industry, promoting fair drug pricing and easier access to medications. With a comprehensive network of pharmacies and suppliers, Trxade Group Inc creates a transparent and efficient marketplace. Its commitment to empowering independent pharmacies has made it a trusted name in the industry. Through continuous advancements and strategic partnerships, Trxade Group Inc continues to shape the future of pharmaceutical commerce.
Trxade Group Inc has achieved several significant milestones in its tenure. The company's key accomplishments include securing a listing on the Nasdaq stock exchange, expanding its reach as a leading web-based pharmaceutical marketplace, and rapidly growing its network of independent pharmacies. Trxade Group Inc has also been recognized for its innovative technologies and solutions, such as its trading platform, which empowers pharmacies to efficiently source medications at competitive prices. This progressive company continues to revolutionize the pharmaceutical industry by connecting independent pharmacies with wholesalers and manufacturers, streamlining operations, and ultimately improving patient access to affordable medications.
Trxade Group Inc is primarily present in the United States.
Trxade Group Inc represents a set of core values and a corporate philosophy that defines its operations. With a focus on transparency, Trxade is dedicated to providing innovative solutions to independent pharmacies, helping them thrive in a competitive industry. The company's commitment to integrity, excellence, and customer-centricity is reflected in its reliable pharmaceutical trading platform and value-added services. Through efficient networking and cost-effective supply chain solutions, Trxade empowers pharmacies to improve patient care while maximizing their profitability. Overall, Trxade Group Inc embodies a customer-first approach, delivering quality products and services to the pharmaceutical industry.
Analyytikot asettavat tällä hetkellä Trxade Group-osakkeelle keskimääräisen tavoitehinnan 6,89 USD (mediaani: 6,89 USD), mikä merkitsee +121,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä Trxade Group-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla Trxade Group-osake noteerataan hintaan 2,71 EUR (3,03 USD).
The Trxade Group Inc is a leading company in the healthcare sector, offering innovative solutions to improve efficiency, quality, and transparency in the pharmaceutical supply chain to businesses and individuals. The company operates multiple divisions and provides a variety of products and services to meet customer needs.
Liikevaihtoa ei voida laskea Trxade Group:lle tällä hetkellä.
Voittoa ei voida laskea Trxade Group:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Trxade Group:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Trxade Group:lle tällä hetkellä.
Trxade Group:n Eulpool-laatuscore on 2/10.
Trxade Group:n ISIN on US89846A2078. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Trxade Group:n ticker on MEDS. Tämä pörssinoteeraus käytetään Trxade Group-osakkeiden kauppaan pörssissä.
Trxade Group osake
Trxade Group vertaisryhmä
Trxade Group FIGI
Kaikki tunnusluvut ja syvällinen analyysi Trxade Group:sta
Meidän osakeanalyysimme Trxade Group-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Trxade Group:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: